AqueSys Microfistula Implant in Refractory Glaucoma

NCT01640756 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-02-08

No results posted yet for this study

Summary

To establish the safety and performance of the AqueSys Microfistula Implant in eyes with refractory glaucoma.

Conditions

Interventions

DEVICE

AqueSys Microfistula Implant

Placement of the AqueSys Microfistula Implant in the study eye

Sponsors & Collaborators

  • AqueSys, Inc.

    lead INDUSTRY

Principal Investigators

  • Richard A Lewis, M.D. · Grutzmacher and Lewis Surgical Eye Specialists

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2014-11-30
Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01640756 on ClinicalTrials.gov